Abstract | CONTEXT: OBJECTIVE: MATERIALS AND METHODS: Male Sprague-Dawely rats were divided into four groups. Group I was control. Group II received Pro (70 mg/kg, orally) once daily for 10 days. Group III received doxorubicin 15 mg/kg i.p. as a single dose on the 7th day and Group IV animals were treated with Pro once daily for 10 days and Dox on the 7th day. The parameters of study were serum biomarkers, cardiac tissue antioxidant status, ECG, and effect on aconitine-induced cardiotoxicity. RESULTS:
Cardiac toxicity of doxorubicin was manifested as a significant increase in heart rate, elevation of the ST segment, prolongation of the QT interval and an increase in T wave amplitude. In addition, Dox enhanced aconitine-induced cardiotoxicity by a significant decrease in the aconitine dose producing ventricular tachycardia (VT). Administration of Pro significantly suppressed Dox-induced ECG changes and normalized the aconitine dose producing VT. The toxicity of Dox was also confirmed biochemically by significant elevation of serum CK-MB and LDH activities as well as myocardial MDA and GSH contents and decrease in serum catalase and myocardial SOD activities. Administration of Pro significantly suppressed these biochemical changes. DISCUSSION AND CONCLUSION:
|
Authors | El-Sayed M Ammar, Shehta A Said, Sally L El-Damarawy, Ghada M Suddek |
Journal | Pharmaceutical biology
(Pharm Biol)
Vol. 51
Issue 3
Pg. 339-44
(Mar 2013)
ISSN: 1744-5116 [Electronic] England |
PMID | 23134235
(Publication Type: Journal Article)
|
Chemical References |
- Antibiotics, Antineoplastic
- Antioxidants
- Biomarkers
- Cardiotonic Agents
- Cardiotoxins
- Grape Seed Extract
- Grape Seed Proanthocyanidins
- Proanthocyanidins
- Voltage-Gated Sodium Channel Agonists
- Doxorubicin
- Aconitine
|
Topics |
- Aconitine
(administration & dosage, antagonists & inhibitors, toxicity)
- Animals
- Antibiotics, Antineoplastic
(adverse effects, antagonists & inhibitors)
- Antioxidants
(therapeutic use)
- Arrhythmias, Cardiac
(etiology, prevention & control)
- Biomarkers
(blood)
- Cardiomyopathy, Dilated
(chemically induced, metabolism, physiopathology, prevention & control)
- Cardiotonic Agents
(therapeutic use)
- Cardiotoxins
(adverse effects, antagonists & inhibitors)
- Doxorubicin
(adverse effects, antagonists & inhibitors)
- Drug Resistance
(drug effects)
- Grape Seed Extract
(therapeutic use)
- Heart
(drug effects, physiopathology)
- Male
- Myocardium
(metabolism)
- Oxidative Stress
(drug effects)
- Phytotherapy
- Proanthocyanidins
(therapeutic use)
- Rats
- Rats, Sprague-Dawley
- Tachycardia
(chemically induced, prevention & control)
- Voltage-Gated Sodium Channel Agonists
(administration & dosage, toxicity)
|